N-Carbamoylsydnonimine zur Verwendung bei der Behandlung von Flavivirusinfektionen
EP4751775
3. Juni 2026
Anmelder: IRBM S.P.A., C.N.C.C.S. S.c.a.r.l. Collezione Nazionale Dei Composti Chimici e Centro Screening 🇮🇹
Details
- Veröffentlichungs-Nr.
- EP4751775
- Anmeldetag
- 27. November 2024
- Veröffentlichung
- 3. Juni 2026
- Rechtsraum
- EP
Abstract
The present invention pertains to compounds that inhibit Flavivirus NS2B-NS3 proteases and are potent and selective inhibitors of the West Nile virus and Zika virus. The compounds of the invention can be used alone or in combination with other agents to treat infections caused by these viruses. Additionally, the invention relates to pharmaceutical compositions containing these compounds.
Anmelder
- Firmen
- IRBM S.P.A.
C.N.C.C.S. S.c.a.r.l. Collezione Nazionale Dei Composti Chimici e Centro Screening - Land
- 🇮🇹 Italien